STADA Arzneimittel Aktiengesellschaft (STDAF) Stock Price, News & Analysis

Company Overview

STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.

Key Stats

• Today's Range: $110.42 to $110.42
• 50-Day Range: $110.42 to $110.42
• 52-Week Range: $75.15 to $115.00
• Volume: N/A
• Average Volume: 180 shs
• Market Capitalization: $6.88 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

STDAF Stock Analysis - Frequently Asked Questions

How have STDAF shares performed this year?

STADA Arzneimittel Aktiengesellschaft's stock was trading at $110.42 on January 1st, 2025. Since then, STDAF shares have increased by 0.0% and is now trading at $110.42.
View the best growth stocks for 2025 here.

How do I buy shares of STADA Arzneimittel Aktiengesellschaft?

Shares of STDAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 4/20/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medicinals & Botanicals
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:STDAF
• Previous Symbol: NASDAQ:STDAF
• CIK: N/A
• Web: www.stada.com
• Phone: (496) 101-6030
• Fax: 49-61-0160-3259
• Employees: 12,500
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 2.23
• Current Ratio: 1.54
• Quick Ratio: 0.99

Sales & Book Value

• Annual Sales: $3.84 billion
• Price / Sales: 1.79
• Cash Flow: $11.12 per share
• Price / Cash Flow: 9.93
• Book Value: $23.11 per share
• Price / Book: 4.78

Miscellaneous

• Outstanding Shares: 62,342,000
• Free Float: N/A
• Market Cap: $6.88 billion
• Optionable: Not Optionable
• Beta: 0.38